Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Disease Biomarkers

Niklas Mattsson's Biography

Niklas Mattsson, Medical Doctor & Researcher, Sahlgrens University Hospital

Dr Mattsson is a medical doctor and researcher at the Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital in Gothenburg/Mölndal, Sweden, where he performs specialized laboratory investigations for neurological diseases.

He received his medical education in Lund and Gothenburg in Sweden and did his doctorate studies at the University of Gothenburg in the research group of Kaj Blennow and Henrik Zetterberg on cerebrospinal fluid biomarkers for axonal degeneration and amyloid metabolism in Alzheimer’s disease, neuroinflammation and inborn errors of metabolism.

His current research is focused on the standardization of cerebrospinal fluid biomarker measurements on an international level within the Alzheimer’s Association quality control program and other initiatives, and within Sweden, where he is an expert consultant for the national laboratory quality assurance organization (EQUALIS). He also works on identification and validation of novel biomarkers for disease progression and effects of disease-modifying therapies.

Niklas Mattsson Image

Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease and Other Dementias

Thursday, 10 May 2012 at 11:15

Add to Calendar ▼2012-05-10 11:15:002012-05-10 12:15:00Europe/LondonCerebrospinal Fluid Biomarkers in Alzheimer’s Disease and Other Dementias

Cerebrospinal fluid biomarkers may be used to monitor disease processes in the brain. Applications are available for research and clinical routine in patient management for several neurological diseases, for diagnosis, prognosis, patient stratification and monitoring of treatment effect and toxicity. Within dementia research, major efforts are devoted to the discovery and validation of biomarkers for different applications in Alzheimer’s disease.

Add to Calendar ▼2012-05-10 00:00:002012-05-11 00:00:00Europe/LondonDisease